{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T18:38:04Z","timestamp":1782758284745,"version":"3.54.5"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100001570","name":"CS Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001570","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013995","name":"Sanofi Genzyme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013995","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004326","name":"Bayer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004326","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002347","name":"Bundesministerium f\u00fcr Bildung und Forschung","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004329","name":"Genzyme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004329","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003493","name":"Gemeinn\u00fctzige Hertie-Stiftung","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003493","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004337","name":"Roche","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004337","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011699","name":"Siemens Healthineers","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011699","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008792","name":"Novartis Pharma","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008792","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005614","name":"Biogen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005614","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinica Chimica Acta"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1016\/j.cca.2019.08.016","type":"journal-article","created":{"date-parts":[[2019,8,19]],"date-time":"2019-08-19T11:22:51Z","timestamp":1566213771000},"page":"148-153","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Association of cerebrospinal fluid kappa free light chains with the intrathecal polyspecific antiviral immune response in multiple sclerosis"],"prefix":"10.1016","volume":"498","author":[{"given":"Andr\u00e9","family":"Huss","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatemeh","family":"Mojib-Yezdani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franziska","family":"Bachhuber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanja","family":"Fangerau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Lewerenz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Otto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hayrettin","family":"Tumani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makbule","family":"Senel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cca.2019.08.016_bb0005","doi-asserted-by":"crossref","DOI":"10.1002\/ana.20703","article-title":"Diagnostic criteria for multiple sclerosis: 2005 revisions to the \u201cMcDonald Criteria\u201d","author":"Polman","year":"2005","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.cca.2019.08.016_bb0010","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1002\/ana.22366","article-title":"Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria","volume":"69","author":"Polman","year":"2011","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.cca.2019.08.016_bb0015","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S1474-4422(17)30470-2","article-title":"Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria","volume":"17","author":"Thompson","year":"2018","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.cca.2019.08.016_bb0020","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.jim.2011.06.009","article-title":"Utility of oligoclonal IgG band detection for MS diagnosis in daily clinical practice","volume":"371","author":"Abraira","year":"2011","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.cca.2019.08.016_bb0025","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.3390\/ijms17091592","article-title":"McDonald criteria 2010 and 2005 compared: persistence of high oligoclonal band prevalence despite almost doubled diagnostic sensitivity","volume":"17","author":"Schwenkenbecher","year":"2016","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.cca.2019.08.016_bb0030","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1001\/archneur.62.6.865","article-title":"Recommended standard of cerebrospinal fluid analysis in the diagnosis of multiple sclerosis: a consensus statement","volume":"62","author":"Freedman","year":"2005","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.cca.2019.08.016_bb0035","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/BF02043963","article-title":"CFS Oligoclonal bands in MS and other neurological diseases detected by agarose isoelectric focusing and electrophoresis","volume":"5","author":"Cerrato","year":"1984","journal-title":"Ital. J. Neurol. Sci."},{"key":"10.1016\/j.cca.2019.08.016_bb0040","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1002\/ana.410130410","article-title":"Oligoclonal IgG bands in cerebrospinal fluid in various neurological diseases","volume":"13","author":"Chu","year":"1983","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.cca.2019.08.016_bb0045","doi-asserted-by":"crossref","first-page":"135","DOI":"10.3109\/00365519609088600","article-title":"Qualitative assessment of intrathecal IgG synthesis by isoelectric focusing and immunodetection: interlaboratory reproducibility and interobserver agreement","volume":"56","author":"Sellebjerg","year":"1996","journal-title":"Scand. J. Clin. Lab. Invest."},{"key":"10.1016\/j.cca.2019.08.016_bb0050","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1373\/clinchem.2007.089052","article-title":"Interlaboratory reproducibility of isoelectric focusing in oligoclonal band detection","volume":"53","author":"Franciotta","year":"2007","journal-title":"Clin. Chem."},{"key":"10.1016\/j.cca.2019.08.016_bb0055","article-title":"Free light chains and intrathecal B cells activity in multiple sclerosis: a prospective study and meta-analysis","volume":"2016","author":"Passerini","year":"2016","journal-title":"Mult. Scler. Int."},{"key":"10.1016\/j.cca.2019.08.016_bb0060","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.jneuroim.2017.05.007","article-title":"KFLC index utility in multiple sclerosis diagnosis: further confirmation","volume":"309","author":"Pieri","year":"2017","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.cca.2019.08.016_bb0065","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1177\/1352458515594044","article-title":"Validation of kappa free light chains as a diagnostic biomarker in multiple sclerosis and clinically isolated syndrome: a multicenter study","volume":"22","author":"Presslauer","year":"2016","journal-title":"Mult. Scler. J."},{"key":"10.1016\/j.cca.2019.08.016_bb0070","article-title":"Cerebrospinal fluid free kappa light chains and kappa index perform equal to oligoclonal bands in the diagnosis of multiple sclerosis","volume":"0","author":"Christiansen","year":"2018","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1016\/j.cca.2019.08.016_bb0075","doi-asserted-by":"crossref","first-page":"641","DOI":"10.3389\/fimmu.2019.00641","article-title":"CSF free light chains as a marker of intrathecal immunoglobulin synthesis in multiple sclerosis: a blood-CSF barrier related evaluation in a large cohort","volume":"10","author":"Senel","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cca.2019.08.016_bb0080","article-title":"Free kappa light chains in cerebrospinal fluid as a biomarker to assess risk conversion to multiple sclerosis","volume":"1","author":"Men\u00e9ndez-Valladares","year":"2015","journal-title":"Mult. Scler. J. Exp. Transl. Clin."},{"key":"10.1016\/j.cca.2019.08.016_bb0085","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1177\/1352458516681503","article-title":"Prognostic value of free light chains lambda and kappa in early multiple sclerosis","volume":"23","author":"Voortman","year":"2017","journal-title":"Mult. Scler. J."},{"key":"10.1016\/j.cca.2019.08.016_bb0090","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0088680","article-title":"Cerebrospinal fluid immunoglobulin kappa light chain in clinically isolated syndrome and multiple sclerosis","volume":"9","author":"Senel","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1016\/j.cca.2019.08.016_bb0095","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1007\/s00415-016-8360-4","article-title":"The MRZ reaction as a highly specific marker of multiple sclerosis: re-evaluation and structured review of the literature","volume":"264","author":"Jarius","year":"2017","journal-title":"J. Neurol."},{"key":"10.1016\/j.cca.2019.08.016_bb0100","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.jneuroim.2018.05.015","article-title":"The intrathecal polyspecific antiviral immune response (MRZ reaction): a potential cerebrospinal fluid marker for multiple sclerosis diagnosis","volume":"321","author":"Feki","year":"2018","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.cca.2019.08.016_bb0105","article-title":"Intrathecal IgG synthesis: a resistant and valuable target for future multiple sclerosis treatments","volume":"2015","author":"Bonnan","year":"2015","journal-title":"Mult. Scler. Int."},{"key":"10.1016\/j.cca.2019.08.016_bb0110","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1080\/14737159.2017.1262260","article-title":"An update on the use of cerebrospinal fluid analysis as a diagnostic tool in multiple sclerosis","volume":"17","author":"Gastaldi","year":"2017","journal-title":"Expert. Rev. Mol. Diagn."},{"key":"10.1016\/j.cca.2019.08.016_bb0115","article-title":"Kappa free light chains is a valid tool in the diagnostics of MS: a large multicenter study","author":"Leurs","year":"2019","journal-title":"Mult. Scler. J."},{"key":"10.1016\/j.cca.2019.08.016_bb0120","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1212\/WNL.0b013e3181c47cc2","article-title":"A consensus protocol for the standardization of cerebrospinal fluid collection and biobanking","volume":"73","author":"Teunissen","year":"2009","journal-title":"Neurology."},{"key":"10.1016\/j.cca.2019.08.016_bb0125","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0022-510X(00)00501-3","article-title":"Cerebrospinal fluid analysis: disease-related data patterns and evaluation programs","volume":"184","author":"Reiber","year":"2001","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.cca.2019.08.016_bb0130","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1515\/CCLM.2001.051","article-title":"Reporting cerebrospinal fluid data: knowledge base and interpretation software","volume":"39","author":"Reiber","year":"2001","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1016\/j.cca.2019.08.016_bb0135","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0022-510X(94)90298-4","article-title":"Flow rate of cerebrospinal fluid (CSF) - a concept common to normal blood-CSF barrier function and to dysfunction in neurological diseases","volume":"122","author":"Reiber","year":"1994","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.cca.2019.08.016_bb0140","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1007\/s00415-016-8094-3","article-title":"Detection of intrathecal immunoglobulin G synthesis by capillary isoelectric focusing immunoassay in oligoclonal band negative multiple sclerosis","volume":"263","author":"Halbgebauer","year":"2016","journal-title":"J. Neurol."},{"key":"10.1016\/j.cca.2019.08.016_bb0145","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0007638","article-title":"IgG antibodies against measles, rubella, and varicella zoster virus predict conversion to multiple sclerosis in clinically isolated syndrome","volume":"4","author":"Brettschneider","year":"2009","journal-title":"PLoS ONE"},{"key":"10.1016\/j.cca.2019.08.016_bb0150","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1016\/S0140-6736(02)08220-X","article-title":"Multiple sclerosis","volume":"359","author":"Compston","year":"2002","journal-title":"Lancet."},{"key":"10.1016\/j.cca.2019.08.016_bb0155","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1136\/jnnp-2018-317947","article-title":"Cerebrospinal fluid immunoglobulin light chain ratios predict disease progression in multiple sclerosis","volume":"89","author":"Rathbone","year":"2018","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.cca.2019.08.016_bb0160","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1515\/cclm-2017-0285","article-title":"Application of \u03ba free light chains in cerebrospinal fluid as a biomarker in multiple sclerosis diagnosis: development of a diagnosis algorithm","volume":"56","author":"Valencia-Vera","year":"2018","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1016\/j.cca.2019.08.016_bb0165","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0089945","article-title":"Kappa free light chains: diagnostic and prognostic relevance in MS and CIS","volume":"9","author":"Presslauer","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1016\/j.cca.2019.08.016_bb0170","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1111\/ane.12969","article-title":"Free kappa light chains in neuroinflammatory disorders: complement rather than substitute?","volume":"138","author":"Bayart","year":"2018","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.cca.2019.08.016_bb0175","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1177\/135245859800400304","article-title":"The intrathecal, polyspecific and oligoclonal immune response in multiple sclerosis","volume":"4","author":"Reiber","year":"1998","journal-title":"Mult. Scler. J."},{"key":"10.1016\/j.cca.2019.08.016_bb0180","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/S0022-510X(97)00272-4","article-title":"Acute optic neuritis: combined immunological markers and magnetic resonance imaging predict subsequent development of multiple sclerosis. The Optic Neuritis Study Group","volume":"155","author":"Tumani","year":"1998","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.cca.2019.08.016_bb0185","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1002\/ana.20890","article-title":"B lineage cells in the inflammatory central nervous system environment: migration, maintenance, local antibody production, and therapeutic modulation","volume":"59","author":"Meinl","year":"2006","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.cca.2019.08.016_bb0190","doi-asserted-by":"crossref","first-page":"S42","DOI":"10.1002\/ana.410360713","article-title":"Histopathology and the blood-cerebrospinal fluid barrier in multiple sclerosis","volume":"36","author":"Lassmann","year":"1994","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.cca.2019.08.016_bb0195","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.jneuroim.2011.01.010","article-title":"Related B cell clones that populate the CSF and CNS of patients with multiple sclerosis produce CSF immunoglobulin","volume":"233","author":"Obermeier","year":"2011","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.cca.2019.08.016_bb0200","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.jneuroim.2004.04.022","article-title":"Receptor revision and atypical mutational characteristics in clonally expanded B cells from the cerebrospinal fluid of recently diagnosed multiple sclerosis patients","volume":"158","author":"Monson","year":"2005","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.cca.2019.08.016_bb0205","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1111\/j.1750-3639.2004.tb00049.x","article-title":"Detection of ectopic B-cell follicles with germinal centers in the meninges of patients with secondary progressive multiple sclerosis","volume":"14","author":"Serafini","year":"2004","journal-title":"Brain Pathol."},{"issue":"Pt 6","key":"10.1016\/j.cca.2019.08.016_bb0210","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1093\/brain\/117.6.1311","article-title":"Patterns of oligodendroglia pathology in multiple sclerosis","volume":"117","author":"Ozawa","year":"1994","journal-title":"Brain."},{"key":"10.1016\/j.cca.2019.08.016_bb0215","doi-asserted-by":"crossref","first-page":"7864","DOI":"10.1073\/pnas.1522730113","article-title":"Distinct oligoclonal band antibodies in multiple sclerosis recognize ubiquitous self-proteins","volume":"113","author":"Br\u00e4ndle","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.cca.2019.08.016_bb0220","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1007\/s00415-016-8302-1","article-title":"Importance of cerebrospinal fluid analysis in the era of McDonald 2010 criteria: a German-Austrian retrospective multicenter study in patients with a clinically isolated syndrome","volume":"263","author":"Huss","year":"2016","journal-title":"J. Neurol."}],"container-title":["Clinica Chimica Acta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898119320042?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898119320042?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T20:02:34Z","timestamp":1762113754000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009898119320042"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11]]},"references-count":44,"alternative-id":["S0009898119320042"],"URL":"https:\/\/doi.org\/10.1016\/j.cca.2019.08.016","relation":{},"ISSN":["0009-8981"],"issn-type":[{"value":"0009-8981","type":"print"}],"subject":[],"published":{"date-parts":[[2019,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association of cerebrospinal fluid kappa free light chains with the intrathecal polyspecific antiviral immune response in multiple sclerosis","name":"articletitle","label":"Article Title"},{"value":"Clinica Chimica Acta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cca.2019.08.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}